Association of sodium–glucose cotransporter‐2 inhibitors and the risk of retinal vascular occlusion: A real‐world retrospective cohort study in Taiwan

Documents similaires

• Association of initial serum sodium change and clinical outcome in patients with diabetes receiving sodium–glucose cotransporter‐2 inhibitor therapy: A multicentre database analysis in Taiwan
  par: Yu‐Wen Cheng, et autres
  Publié: (2024)
• Cost‐effectiveness of sodium‐glucose cotransporter‐2 inhibitors in the treatment of diabetic nephropathy in Japan
  par: Keiko Maruyama‐Sakurai, et autres
  Publié: (2024)
• Comparing clinical outcomes in patients with type 2 diabetes mellitus after ischaemic stroke: Sodium–glucose cotransporter 2 inhibitors users versus non‐users. A propensity score matching National Cohort Study
  par: Tzu‐Yang Chen, et autres
  Publié: (2024)
• Use of sodium‐glucose cotransporter‐2 inhibitors in France: Analysis of French nationwide health insurance database
  par: Sibylle de Germay, et autres
  Publié: (2024)
• Incidence and progression of diabetic retinopathy in patients treated with glucagon‐like peptide‐1 receptor agonists versus sodium‐glucose cotransporter 2 inhibitors: A population‐based cohort study
  par: Donna Shu‐Han Lin, et autres
  Publié: (2024)